Association between STAT3 gene Polymorphisms and Crohn’s diseasesusceptibility: a case–control study in a Chinese Han population

Crohn’s disease (CD) and ulcerative colitis (UC) are inflammatory boweldiseases (IBDs). The etiology and pathogenesis of CD are not completely understood.However, familial aggregation and twin studies report that patients with CD carrystrong genetic predisposition [1]. Several studies also strongly suggest that CD results from a combinationof factors, such as commensal bacteria, food antigens, immunologic factors andmultiple genetic factors [2, 3]. The signal transducer and activator of transcription 3 (STAT3) gene is apotential candidate gene for CD for several reasons. STAT3 is a member of STATfamily, which possesses an important function in the development of human immunesystem and haematopoiesis. This gene has been associated with the signaltransduction pathway of multiple cytokines, including IL-2/γc, IL-6/gp130, IFNand IL-10 families, as well as IL-12, IL- 23, Flt3 ligand, M-CSF, G-CSF, leptin andgrowth hormone [4‐9]. Several studies have highlighted that the STAT3 signaling pathway isimportant in the occurrence and development of IBD both in patients and animalmodels [10‐13].

In 2008, Barrett et al. [14] reported that the STAT3 locus is significantly associated with CDsusceptibility in a genome-wide association study (GWAS). Since then, a number ofstudies have demonstrated that the polymorphisms of STAT3 are associated with CD aswell as UC, but their results are not consistent in different population cohorts [15‐20]. Therefore, we performed an analysis on three polymorphisms (rs2293152,rs4796793 and rs744166) of STAT3 and CD in Chinese Han population.

Table 2 shows detailed information of patients andcontrols. Cases and controls were well matched by age and gender distribution.

Table 3 shows that a significant difference was observedfor rs744166 between CD patients and controls both in allele and genotypedistributions (P allele = 0.0008, andP genotype = 0.003). A significant decreased risk was identifiedfor rs744166 in association with CD under the additive [odds ratio(OR) = 0.63; 95% confidence interval (CI): 0.48–0.83], dominant(OR = 0.61; 95% CI: 0.43–0.81) and recessive(OR = 0.43; 95% CI: 0.24–0.77) models.

As for rs4796793, a significant difference was observed between the two groups inallele but not in genotype distribution (P allele = 0.03 andP genotype = 0.07). Meanwhile, a significant decreased riskwas found in association with CD under the additive (OR = 0.75; 95% CI:0.58–0.98) and recessive (OR = 0.53; 95% CI: 0.30–0.95)models, whereas no significant association was detected under the dominant model(OR = 0.76; 95% CI: 0.57–1.09).

No significant difference was observed in the genotype and allele distributions ofrs2293152 between CD patients and controls. This result also agrees under theassumptions of the additive (OR = 0.94; 95% CI: 0.73–1.23),dominant (OR = 1.19; 95% CI: 0.80–1.77) and recessive(OR = 0.66; 95% CI: 0.42–1.05) models.

CD is a relapsing inflammatory condition of gastrointestinal mucosal damage withcharacteristic extra-intestinal manifestations [22, 23]. CD is widely known as an immune-related disease with geneticpredisposition. Given the importance of immunity in CD, investigations onCD-susceptibility genes that involve immunity have attracted considerable attention [24, 25].

The STAT3 gene is located on chromosome 17q21. Its protein product is a member of theSTAT protein family that performs a dual function: signal transduction andtranscription activation. STAT3 is widely expressed and a latent cytoplasmictranscription factor that relays signals from the cell membrane directly to thenucleus. STAT3 becomes activated through phosphorylation on tyrosine as aDNA-binding protein in response to a variety of stimuli and mediates the expressionof a variety of genes. Thus, STAT3 possesses a key function in many biologicalpathways crucial to cell function, including proliferation, migration, survival anddifferentiation [26]. Several studies indicated that STAT3 activation plays distinctlydifferent roles between innate and acquired immune responses in colitis, that is,activation of STAT3 in innate immune cells enhances mucosal barrier function andSTAT3 activation in T-cells exacerbates colitis [11, 12]. A number of studies also suggest that polymorphisms of STAT3 areassociated with the susceptibility of CD or UC in some population cohorts [15‐20].

We examined three polymorphisms of STAT3 in 232 CD patients and 272 normal controlsof Chinese Han population. Results revealed that both the STAT3 gene alleles ofrs4796793G and rs744166C reduced the risk of CD occurrence and may have a protectivefunction in CD. To the authors' knowledge, this is the pilot study that explored thegenetic susceptibility of STAT3 gene to CD in a Chinese population.

The rs744166, which was first identified as an important candidate susceptibilitylocus for CD in a GWAS research [14], was confirmed in a Chinese population in this study. Our results are inagreement with those previously published data in a New Zealand population [17]. They found a significant decrease in the frequency of the G allele ofrs744166 in CD patients compared with controls (OR = 0.76, 95%CI = 0.61–0.95, P = 0.013), and G allele maybe protective against CD. However, Franke et al. [15] failed to replicate the association between rs744166 and CD risk in aGerman population. This discrepancy may be mostly due to the heterogeneous geneticpredispositions in people of different ethnicities. The genetic markers inpredisposition to IBD vary across geographical and racial groups. In our previousmeta-analyses, the CD14 gene C-260 T polymorphism exhibits remarkableheterogeneity with UC across ethnic groups, which is significant in Asians but notin Caucasians [27]. However, given the relatively small samples in this study, more studiesare required to reliably quantify the effect of rs744166.

rs2293152, a STAT3 variant, has been reported to be significantly associated with CDin Japanese population [16]. This variant did not show significant association between CD patient andnormal control groups in this study. Sample size may be one of the majordeterminants because both studies (Sato’s research and our study) selectedEast Asia population. Sato’s study only enrolled 83 CD cases and 200 healthycontrols, whereas our study included 232 CD cases and 272 normal controls. Given thelarger sample size, our result seems more reliable. We could not exclude thedifferent population results in different genetic backgrounds.

In the present study, a new candidate locus, rs4796793, was found, which wasassociated with CD in Chinese population. This association is not reported in otherstudies. Therefore, further studies should be carried out to verify this associationusing a large sample size from different ethnic origins and biological research.

This study has some drawbacks. First, the sample size was not very large; thus, moreSNP sites for pair-loci D'/r2 value analysis and haplotype analysis on a largernumber of Chinese subjects and on other ethnicities are necessary to confirm theassociation more clearly. Second, we only revealed limited polymorphisms of STAT3gene associated with susceptibility to CD, and other unidentified polymorphisms,which influenced the development of CD, may still exist. Third, our results werebased on unadjusted estimates. STAT3 gene polymorphisms of rs4796793 and rs744166individually make a protective contribution against CD, but whether thepolymorphisms integrated with other risk factors will change the prediction requiresadditional research. Thus, a more precise analysis should be conducted withindividual data, which would allow for the adjustment by other co-varieties, such asage, gender, lifestyle and other genetic factors.

In conclusion, this study is the first to demonstrate the single-marker associationof STAT3 with CD susceptibility in the Chinese Han population. We confirmed thatSTAT3 rs744166 and rs4796793 polymorphisms were associated with CD occurrence andused as a predictive factor of CD in Chinese Han populations.However, the diversegenetic profiles across different ethnic groups remain unclear.